Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

248 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Standardized gait speed ratio in elderly patients with heart failure.
Ozawa T, Yamashita M, Seino S, Kamiya K, Kagiyama N, Konishi M, Saito H, Saito K, Ogasahara Y, Maekawa E, Kitai T, Iwata K, Jujo K, Wada H, Kasai T, Momomura SI, Hamazaki N, Nozaki K, Kim H, Obuchi S, Kawai H, Kitamura A, Shinkai S, Matsue Y. Ozawa T, et al. Among authors: kagiyama n. ESC Heart Fail. 2021 Oct;8(5):3557-3565. doi: 10.1002/ehf2.13392. Epub 2021 Jul 10. ESC Heart Fail. 2021. PMID: 34245132 Free PMC article.
Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction.
Matsue Y, Suzuki M, Torii S, Yamaguchi S, Fukamizu S, Ono Y, Fujii H, Kitai T, Nishioka T, Sugi K, Onishi Y, Noda M, Kagiyama N, Satoh Y, Yoshida K, Goldsmith SR. Matsue Y, et al. Among authors: kagiyama n. J Card Fail. 2016 Jun;22(6):423-32. doi: 10.1016/j.cardfail.2016.02.007. Epub 2016 Feb 23. J Card Fail. 2016. PMID: 26915749 Clinical Trial.
Prognostic impact of early treatment with tolvaptan in patients with acute heart failure and renal dysfunction.
Matsue Y, Suzuki M, Torii S, Yamaguchi S, Fukamizu S, Ono Y, Fujii H, Kitai T, Nishioka T, Sugi K, Onishi Y, Noda M, Kagiyama N, Satoh Y, Yoshida K, Goldsmith SR. Matsue Y, et al. Among authors: kagiyama n. Int J Cardiol. 2016 Oct 15;221:188-93. doi: 10.1016/j.ijcard.2016.07.063. Epub 2016 Jul 5. Int J Cardiol. 2016. PMID: 27404673 Clinical Trial.
Corrigendum to "Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction" Journal of Cardiac Failure, Vol. 22, No. 6, June 2016, pp. 423-432.
Matsue Y, Suzuki M, Torii S, Yamaguchi S, Fukamizu S, Ono Y, Fujii H, Kitai T, Nishioka T, Sugi K, Onishi Y, Noda M, Kagiyama N, Satoh Y, Yoshida K, Goldsmith SR. Matsue Y, et al. Among authors: kagiyama n. J Card Fail. 2016 Nov;22(11):941. doi: 10.1016/j.cardfail.2016.07.434. Epub 2016 Jul 29. J Card Fail. 2016. PMID: 27481596 No abstract available.
Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction.
Matsue Y, Ter Maaten JM, Suzuki M, Torii S, Yamaguchi S, Fukamizu S, Ono Y, Fujii H, Kitai T, Nishioka T, Sugi K, Onishi Y, Noda M, Kagiyama N, Satoh Y, Yoshida K, van der Meer P, Damman K, Voors AA, Goldsmith SR. Matsue Y, et al. Among authors: kagiyama n. Clin Res Cardiol. 2017 Oct;106(10):802-812. doi: 10.1007/s00392-017-1122-1. Epub 2017 May 24. Clin Res Cardiol. 2017. PMID: 28540483 Free PMC article. Clinical Trial.
Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart Failure.
Matsue Y, Damman K, Voors AA, Kagiyama N, Yamaguchi T, Kuroda S, Okumura T, Kida K, Mizuno A, Oishi S, Inuzuka Y, Akiyama E, Matsukawa R, Kato K, Suzuki S, Naruke T, Yoshioka K, Miyoshi T, Baba Y, Yamamoto M, Murai K, Mizutani K, Yoshida K, Kitai T. Matsue Y, et al. Among authors: kagiyama n. J Am Coll Cardiol. 2017 Jun 27;69(25):3042-3051. doi: 10.1016/j.jacc.2017.04.042. J Am Coll Cardiol. 2017. PMID: 28641794 Free article.
248 results